Music Perception in SeLECTs
EpiMUS
Music and Cognitive Deficits in Self-Limited Epilepsy with Centrotemporal Spikes
1 other identifier
observational
100
1 country
2
Brief Summary
Self-limited epilepsy with centrotemporal spikes (SeLECTS) is the most frequent epilepsy syndrome in children between the ages of 4 and 13 years. SeLECTS is associated in 15 to 30% of patients with specific cognitive deficits, including in particular disorders in language, visuo-spatial memory, declarative memory, and attention. SeLECTS has the potential to evolve into Landau-Kleffner syndrome, the most extreme form of SeLECTS including symptoms of auditory agnosia and aphasia, with potential risks of persistent neuropsychological impairments. In a recent study in adults who had suffered Landau-Kleffner syndrome during childhood, the investigators have shown that these patients, in addition to their known deficit in verbal short-term memory, also exhibit persistent musical difficulties during adulthood, with in particular deficit in melody and rhythm short-term memory. In the present project, the investigators intend to enlarge the understanding of cognitive deficits generated by SeLECTS in children by investigating the integrity of music perception, both for melody and rhythm. To date, data about music perception in children with epilepsy are scarce and we do not know how distinct components of melody and rhythm perception and memory may be altered.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2024
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 10, 2024
CompletedFirst Posted
Study publicly available on registry
August 9, 2024
CompletedStudy Start
First participant enrolled
November 13, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2026
December 9, 2024
December 1, 2024
2 years
July 10, 2024
December 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Performance obtained in melodic tasks
Comparison between controls and patients using Bayesian ANOVAs to the percentages of correct responses obtained with melodic tasks
2 Years
Performance obtained in melodic tasks
Comparison between controls and patients using Bayesian ANOVAs to response times obtained with melodic tasks;
2 Years
Performance obtained in rhythmic tasks
Comparison between controls and patients using Bayesian ANOVAs to the percentages of correct responses obtained with rhythmic tasks
2 Years
Performance obtained in rhythmic tasks
Comparison between controls and patients using Bayesian ANOVAs to response times obtained with rhythmic tasks.
2 Years
Study Arms (2)
Patients
This group consists of children and adolescents between the ages of 5 and 14, diagnosed with self-limited epilepsy with centrotemporal spikes by a medical professional (epileptologist or neurologist), and in the active phase of the disorder.
Controls
This group consists of healthy individuals between 5 and 14 years old, with no history of epilepsy and/or other neurodevelopmental disorders.
Interventions
This group consists of children and adolescents between the ages of 5 and 14, diagnosed with self-limited epilepsy with centrotemporal spikes by a medical professional (epileptologist or neurologist), and in the active phase of the disorder.
Eligibility Criteria
The participants will be recruited from a population of 5 to 14 years of age. 50 healthy control participants will be recruited by posting flyers and/or by electronic message, and 50 epileptic patients will be recruited within the HFME child epileptology department (HCL). Their inclusion will be made at the CRNL or HFME by one of the study investigators.
You may qualify if:
- Subject aged between 5 and 14 years old
- Non-opposition of parents or guardians for the child's participation in the study
- No major cognitive impairment and ability to understand and apply instructions
- Subject affiliated to a social security scheme
- Subject motivated to participate in the project
- Proficiency with the French language
- For the group of control participants:
- Without neurological or psychiatric history
- For the group of participants with seizure disorder:
- No neurological (except EPCT) or psychiatric history
- Diagnosis of self-limited epilepsy with centro-temporal spikes (PTSE) by a qualified healthcare professional.
You may not qualify if:
- Major cognitive impairment or inability to understand and apply instructions
- Individuals refusing to participate in the study
- Pregnant or breastfeeding minors
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Centre Hospitalier Le Vinatier (Bât. 452),
Bron, Bron, 69500, France
Hospices Civils de Lyon
Bron, Bron, 69500, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 10, 2024
First Posted
August 9, 2024
Study Start
November 13, 2024
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
November 1, 2026
Last Updated
December 9, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share